Analytical Data
-
基因名
TFAP4
- Application
-
别名
Transcription factor AP-4. Activating enhancer-binding Protein 4. Class C basic helix-loop-helix Protein 41. bHLHc41
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q01664
-
表达区间
1-338 aa
-
氨基酸序列
MEYFMVPTQKVPSLQHFRKTEKEVIGGLCSLANIPLTPETQRDQERRIRREIANSNERRRMQSINAGFQSLKTLIPHTDGEKLSKAAILQQTAEYIFSLEQEKTRLLQQNTQLKRFIQELSGSSPKRRRAEDKDEGIGSPDIWEDEKAEDLRREMIELRQQLDKERSVRMMLEEQVRSLEAHMYPEKLKVIAQQVQLQQQQEQVRLLHQEKLEREQQQLRTQLLPPPAPTHHPTVIVPAPPPPPSHHINVVTMGPSSVINSVSTSRQNLDTIVQAIQHIEGTQEKQELEEEQRRAVIVKPVRSCPEAPTSDTASDSEASDSDAMDQSREEPSGDGELP
-
分子量
65.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TFAP4, or Transcription Factor AP-4, is a crucial member of the AP-1 superfamily of transcription factors, and it plays a significant role in various biological processes, including cell proliferation, differentiation, and apoptosis. Its expression is particularly evident in specific tissues and during developmental stages, suggesting that it is essential for normal physiological functions. Research has indicated that TFAP4 may be involved in tumorigenesis and various diseases, making it a potential target for therapeutic interventions. The recombinant protein of TFAP4 is engineered to study its structure-function relationships, regulatory mechanisms, and interactions with other biomolecules. By producing TFAP4 as a recombinant protein, researchers aim to elucidate its role in gene expression regulation and cellular signaling pathways. This foundational understanding is critical for exploring TFAP4's potential in clinical applications, including cancer therapy and regenerative medicine. As the interest in target-specific therapies grows, characterizing TFAP4 through recombinant techniques can provide insights into its function and contribute to the development of novel therapeutic strategies.
